shutterstock_733304170_casimiro_pt

Casimiro PT / Shutterstock.com

3 December 2019AmericasRory O'Neill

Munich court rules for Bio-Rad in 10x Genomics dispute

California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

10x Genomics strikes back in Bio-Rad saga with USITC ban

13 February 2020 US biotechnology company 10x Genomics has won an import ban against its rival Bio-Rad Laboratories in a long-running patent dispute.

UPC: Milan confirmed as third seat but Munich lands chemistry, minus SEPs

27 June 2023 UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs.

More on this story

10x Genomics strikes back in Bio-Rad saga with USITC ban

13 February 2020 US biotechnology company 10x Genomics has won an import ban against its rival Bio-Rad Laboratories in a long-running patent dispute.

UPC: Milan confirmed as third seat but Munich lands chemistry, minus SEPs

27 June 2023 UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs.

More on this story

10x Genomics strikes back in Bio-Rad saga with USITC ban

13 February 2020 US biotechnology company 10x Genomics has won an import ban against its rival Bio-Rad Laboratories in a long-running patent dispute.

UPC: Milan confirmed as third seat but Munich lands chemistry, minus SEPs

27 June 2023 UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs.

More features

President Trump 2.0: Five major areas to watch

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug